IONS - Ionis Pharmaceuticals Inc
IEX Last Trade
47.67
-2.230 -4.678%
Share volume: 2,110,439
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$49.90
-2.23
-4.47%
Summary score
13%
Profitability
8%
Dept financing
24%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.69%
Return on assets
-2.54%
Return on sales
-53.43%
Return on invested capital
290.52%
Total debt ratio
77.42%
Debt ratio change over timeo
-1.49%
Current Ratio
7.79%
Quick Ratio
7.71%
Cash Position Ratio
7.08%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-30.6%
Return on assets
-3.24%
Return on sales
-63.92%
Return on invested capital
-133.61%
Total debt ratio
88.95%
Debt ratio change over timeo
1.27%
Current Ratio
6.82%
Quick Ratio
6.74%
Cash Position Ratio
6.06%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-25.13%
Return on assets
-2.46%
Return on sales
-29.34%
Return on invested capital
-119.22%
Total debt ratio
90.2%
Debt ratio change over time
-1.76%
Current Ratio
7.61%
Quick Ratio
7.51%
Cash Position Ratio
6.79%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-65.69%
Return on assets
-101.81%
Return on sales
-168.26%
Return on invested capital
-661.7%
Total debt ratio
-149.19%
Debt ratio change over time
-1.49%
Current Ratio
-2.26%
Quick Ratio
-2.25%
Cash Position Ratio
-1.99%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IONS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.69% | 15.05% | 35.64% | 7.13% |
| Return on assets | -2.54% | 2.88% | 3.13% | 5.53% |
| Return on sales | -53.43% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 290.52% | 2.57% | 5.37% | 18.48% |
| Profitability | 25% | 42% | 60% | 57% |
| Total debt ratio | 77.42% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.49% | 326.95% | -8.44% | 1.18% |
| Dept financing | 21% | 50% | 25% | 7% |
| Current Ratio | 6.82% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 6.74% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 6.06% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 7% | 14% | 35% |
| Short-term ratios | IONS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -30.6% | 13.14% | 10.88% | 4.07% |
| Return on assets | -3.24% | 2.1% | 1.54% | 3.03% |
| Return on sales | -63.92% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -133.61% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 88.95% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | 1.27% | 51.04% | -101.54% | 1.43% |
| Dept financing | 24% | 50% | 25% | 7% |
| Current Ratio | 6.82% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 6.74% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 6.06% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 8% | 17% | 49% |